Leiv Arne Rosseland

Prof. Leiv Arne Rosseland

University of Oslo, Oslo, Norway
orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2008 in Anesthesiology
Verified
Journal Article
Closed access
PDF file
ELEldrid Langesæter
Eldrid Langesæter
LRLeiv Arne Rosseland
Leiv Arne Rosseland
ASAudun Stubhaug
Audun Stubhaug
HYPOTENSION after subarachnoid block for cesarean delivery is common, and several different interventions for the prevention of hypotension have been investigated.1 Cyna et al. 1 concluded in the last Cochrane Review that no single method completely prevents hypotension during cesarean delivery. Most of the studies use a high dose of local anesthetic in the spinal solution, which may be the main cause of hypotension. Previous studies2,3 have shown that reducing the dose reduces the incidence of hypotension. In 2005, Ngan Kee et al. 4 published a study that seemed to have solved the problem with only 1.9% hypotension. They used high doses of intravenous phenylephrine and a high volume of cohydration. The aim of the anesthetic regimen chosen should be to preserve hemodynamic stability of the patients, including uterine blood flow. All previous studies have used noninvasive hemodynamic monitoring, typically measuring blood pressure every minute or even less frequently. Invasive monitoring gives continuous measurements of blood pressure, systemic vascular resistance (SVR), and cardiac output (CO) and may increase our understanding of hemodynamic changes during spinal anesthesia and cesarean delivery.

1 February 2012 in Journal Of Hypertension
Verified
Journal Article
Closed access
GGGuro Grindheim
Guro Grindheim
MEMette-Elise Estensen
Mette-Elise Estensen
ELEldrid Langesaeter
Eldrid Langesaeter
LRLeiv Arne Rosseland
Leiv Arne Rosseland
KTKarin Toska
Karin Toska
Objective: To study longitudinally changes in blood pressure (BP) and heart rate (HR) during healthy pregnancies and to evaluate the influence of parity, pregestational overweight, and excessive weight gain. Methods: A prospective longitudinal cohort study of 57 healthy white women with singleton pregnancies. BP and HR were measured repeatedly at gestational age 14–16 weeks, 22–24 weeks, 30–32 weeks, 36 weeks, and 6 months postpartum using both an oscillometric measurement device (Dinamap) and finger arterial pressure (Finometer PRO). Results: SBP, DBP, and mean arterial pressure (MAP) reached a statistically significant trough at gestational age 22–24 weeks using both measurement devices. When compared with the nonpregnant measurement, SBP at gestational age 22–24 weeks was 6.2 mmHg [95% confidence interval (95% CI) 1.3–11.2] lower measured by Finometer and 7.2 mmHg (95% CI 4.2–10.1) lower measured by Dinamap. DBP and MAP were 8.9 mmHg (95% CI 4.6–13.2) and 9.8 mmHg (95% CI 5.3–14.2) lower measured by Finometer. Measured by Dinamap, DBP and MAP were 4.5 mmHg (95% CI 1.7–7.3) and 5.4 mmHg (95% CI 2.8–7.9) lower at gestational age 22–24 weeks when compared with the nonpregnant state. SBP was significantly higher in women with pregestational BMI at least 25 kg/m2 with both measurement devices (both P < 0.05). There were no differences in SBP, DBP, or MAP depending on parity or excessive weight gain. Conclusion: BP measured repeatedly by two different noninvasive devices during pregnancy and postpartum showed a statistically significant drop in mid-pregnancy, followed by a progressive increase until term.

1 December 2004 in Pain
Verified
Journal Article
Closed access
LRLeiv Arne Rosseland
Leiv Arne Rosseland
ASAudun Stubhaug
Audun Stubhaug
A gender difference in the incidence of acute pain may be a confounder in analgesic trials. We have tested the hypothesis that the incidence of acute pain after knee arthroscopic procedures is greater in women than men. We performed three RCTs on intra-articular analgesics in which no postoperative analgesia was given until the need for such treatment was documented by scoring moderate-to-severe pain on a verbal rating scale (VRS 0-4; n=219), and a 0-100 mm visual analogue pain scale (VAS) within 2 h postoperatively. All trials were performed with an intra-articular catheter technique. The design allowed us to study the natural course of pain after arthroscopic surgery until analgesia was required. Women reported more pain of at least moderate intensity than men (84 vs 57%; P<0.0001), indicating that being female is a risk factor for early postoperative pain (RR 1.47, 95% confidence interval from 1.23 to 1.74). The VAS score corresponding to moderate and severe pain is similar in men and women. Only short acting anaesthetics were given in order to minimise carry-over effects. Since previous trials on arthroscopic analgesics neither measured baseline pain nor stratified for gender, a difference between treatment groups could result from an uneven distribution regarding these factors. Our findings have major implications for the interpretation of previously published trials on intra-articular analgesia.

1 September 2013 in Anesthesiology
Verified
Journal Article
Closed access
PDF file
LRLeiv Arne Rosseland
Leiv Arne Rosseland
THTor Hugo Hauge
Tor Hugo Hauge
GGGuro Grindheim
Guro Grindheim
ASAudun Stubhaug
Audun Stubhaug
ELEldrid Langesæter
Eldrid Langesæter
Background: Little is known about maternal hemodynamics after Cesarean delivery. Uterine contractions may increase cardiac output. Oxytocin is the first-line treatment for uterine atony, although the effects of the long-acting oxytocin analogue carbetocin are comparable with that of oxytocin. The authors analyzed the effects of i.v. oxytocin 5 U, carbetocin 100 µg, and placebo on hemodynamics, uterine tone, adverse events, and blood loss after Cesarean delivery. Methods: This was a randomized, double-blinded, placebo-controlled, parallel-group comparison of carbetocin and oxytocin after elective Cesarean delivery of singletons under spinal anesthesia (n = 76). Continuously measured invasive systolic arterial pressure was the primary outcome measure. Results: The mean systolic arterial pressure decrease was 28 mmHg (95% CI, 22–34) after oxytocin and 26 mmHg (95% CI, 20–31) after carbetocin. The decrease was greatest after 80 (95% CI, 71–89) and 63 s (95% CI, 55–72), respectively (P = 0.006). The differences were nearly undetectable after 2.5 min, although the effect of carbetocin was slightly greater than placebo (P < 0.001). The group differences in systolic arterial pressure decreased over 5 min and were gone at 1 h. Heart rate and cardiac output increased in all three groups. Stroke volume increased after oxytocin and carbetocin but was unchanged after placebo. Conclusions: The hemodynamic side effects of oxytocin 5 U and carbetocin 100 µg were comparable. The lack of an increase in stroke volume in the placebo group challenges the theory that uterine contraction causes autotransfusion of uterine blood, leading to an increase in preload.

1 February 2019 in Intensive and Critical Care Nursing
Verified
Journal Article
Closed access
HAHanne Birgit Alfheim
Hanne Birgit Alfheim
KHKristin Hofsø
Kristin Hofsø
MSMilada Cvancarova Småstuen
Milada Cvancarova Småstuen
KTKirsti Tøien
Kirsti Tøien
LRLeiv Arne Rosseland
Leiv Arne Rosseland
TRTone Rustøen
Tone Rustøen

1 February 2013 in Pain
Verified
Journal Article
Closed access
RORoy Bjørkholt Olsen
Roy Bjørkholt Olsen
SBStephen Bruehl
Stephen Bruehl
CNChristopher Sivert Nielsen
Christopher Sivert Nielsen
LRLeiv Arne Rosseland
Leiv Arne Rosseland
AEAnne Elise Eggen
Anne Elise Eggen
ASAudun Stubhaug
Audun Stubhaug
Resting blood pressure (BP) is inversely related to pain sensitivity in individuals free of chronic pain, reflecting homeostatic interactions between cardiovascular and pain modulatory systems. Several laboratory studies indicate that BP-related hypoalgesia is diminished in chronic pain patients, suggesting dysfunction in these interacting systems. Separate epidemiological findings reveal elevated hypertension prevalence in the chronic pain population. This study for the first time simultaneously evaluated both hypertension prevalence and BP-related hypoalgesia as they relate to chronic pain in the same sample. Resting BP and pain sensitivity were evaluated in a large general population sample (n=10,135, aged 30-87years). Subjects participated in a standardized 106s cold pressor test, providing pain ratings at 9s intervals. Self-reported presence of chronic pain and history of hypertension and use of antihypertensive medication were assessed. Significant interactions between chronic pain status and resting systolic (P<.001) and diastolic BP (P<.001) on mean pain ratings were observed. These interactions were due to significant (P<.001) BP-related hypoalgesia in individuals free of chronic pain that was twice the magnitude of the hypoalgesia observed in the group reporting chronic pain. Presence of chronic pain was associated with significantly increased odds of comorbid hypertension (P<.001). Within the chronic pain group, higher chronic pain intensity was a significant predictor of positive hypertension status beyond the effects of traditional demographic risk factors (P<.05). Results are consistent with the hypothesis that increased hypertension risk in the chronic pain population might be linked in part to chronic pain-related dysfunction in interacting cardiovascular-pain modulatory systems.